JB Chemicals & Pharmaceuticals Ltd. (IN:JBCHEPHARM)
:JBCHEPHARM
Want to see IN:JBCHEPHARM full AI Analyst Report?
JBCHEPHARM Stock Chart & Stats
₹1847.80
-₹0.05(>-0.01%)
At close: 4:00 PM EST
₹1847.80
-₹0.05(>-0.01%)
Day’s Range― - ―
52-Week Range₹1,495.00 - ₹2,195.00
Previous CloseN/A
Volume153.25K
Average Volume (3M)2.67K
Market Cap
₹321.75B
Enterprise Value₹328.22B
Total Cash (Recent Filing)₹9.01B
Total Debt (Recent Filing)₹409.10M
Price to Earnings (P/E)36.0
Beta0.47
Next Earnings
May 21, 2026EPS Estimate
9.9Next Dividend Ex-DateN/A
Dividend Yield0.86%
Share Statistics
EPS (TTM)12.70
Shares Outstanding160,558,700
10 Day Avg. Volume4,569
30 Day Avg. Volume2,671
Financial Highlights & Ratios
PEG Ratio1.96
Price to Book (P/B)7.17
Price to Sales (P/S)6.37
P/FCF Ratio30.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)61.47
Revenue Forecast (FY)₹47.93B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthA substantial increase in annual revenue signals durable demand for the company’s products and successful market penetration. Sustained top-line expansion provides scale advantages, funds R&D and commercialization, and supports long-term investment in product portfolios and distribution capabilities.
Margin ExpansionImproving gross and operating margins indicate effective cost management and pricing power in branded generics. Persistent margin expansion supports cash generation and reinvestment capacity, enhancing resilience to input cost swings and enabling sustainable shareholder returns over the medium term.
Strong Balance SheetLow leverage and a high equity ratio provide financial flexibility to fund organic growth, acquisitions, or downturns without straining liquidity. A robust balance sheet reduces refinancing risk and supports consistent capital allocation toward strategic projects and working capital needs.
Bears Say
CapEx Volatility RiskVariability in capital spending can compress free cash flow in weaker years and complicate long-term investment planning. If capex spikes are required for capacity or regulatory compliance, they may reduce cash available for dividends, debt reduction, or M&A, affecting strategic flexibility.
Limited Investor CommunicationsThe absence of earnings call disclosures limits management's visibility and ongoing guidance to investors, making forecasting and confidence building harder. Persistent communication gaps can increase perceived information risk and deter long-term institutional holders who rely on regular dialogue.
Low Trading LiquidityRelatively low average trading volume can hinder large investors from building or exiting positions without moving prices. Limited liquidity elevates transaction costs and may reduce the pool of potential long-term institutional investors, which can constrain demand and secondary-market stability.
JB Chemicals & Pharmaceuticals Ltd. News
JBCHEPHARM FAQ
What was JB Chemicals & Pharmaceuticals Ltd.’s price range in the past 12 months?
JB Chemicals & Pharmaceuticals Ltd. lowest stock price was ₹1495.00 and its highest was ₹2195.00 in the past 12 months.
What is JB Chemicals & Pharmaceuticals Ltd.’s market cap?
JB Chemicals & Pharmaceuticals Ltd.’s market cap is ₹321.75B.
When is JB Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date?
JB Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date is May 21, 2026 which is in 23 days.
How were JB Chemicals & Pharmaceuticals Ltd.’s earnings last quarter?
JB Chemicals & Pharmaceuticals Ltd. released its earnings results on Jan 16, 2026. The company reported ₹12.7 earnings per share for the quarter, beating the consensus estimate of ₹12.3 by ₹0.4.
Is JB Chemicals & Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts JB Chemicals & Pharmaceuticals Ltd.’s price is currently Overvalued.
Does JB Chemicals & Pharmaceuticals Ltd. pay dividends?
JB Chemicals & Pharmaceuticals Ltd. pays a Semiannually dividend of ₹7 which represents an annual dividend yield of 0.86%. See more information on JB Chemicals & Pharmaceuticals Ltd. dividends here
What is JB Chemicals & Pharmaceuticals Ltd.’s EPS estimate?
JB Chemicals & Pharmaceuticals Ltd.’s EPS estimate is 9.9.
How many shares outstanding does JB Chemicals & Pharmaceuticals Ltd. have?
JB Chemicals & Pharmaceuticals Ltd. has 160,558,700 shares outstanding.
What happened to JB Chemicals & Pharmaceuticals Ltd.’s price movement after its last earnings report?
JB Chemicals & Pharmaceuticals Ltd. reported an EPS of ₹12.7 in its last earnings report, beating expectations of ₹12.3. Following the earnings report the stock price went up 0.388%.
Which hedge fund is a major shareholder of JB Chemicals & Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IN:JBCHEPHARM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
JB Chemicals & Pharmaceuticals Ltd.
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.
Technical Analysis
Ajanta Pharma Limited
―
Emcure Pharmaceuticals Limited
―
Eris Lifesciences Ltd
―
IPCA Laboratories Limited
―
Wockhardt Limited
―